Oral acyclovir for prevention of herpes simplex virus reactivation after marrow transplantation.
暂无分享,去创建一个
N. Flournoy | J. Meyers | J. Wade | B. Newton
[1] J. Meyers,et al. Frequency and significance of acyclovir-resistant herpes simplex virus isolated from marrow transplant patients receiving multiple courses of treatment with acyclovir. , 1983, The Journal of infectious diseases.
[2] L. Corey,et al. Herpes simplex virus pneumonia: clinical, virologic, and pathologic features in 20 patients. , 1982, Annals of internal medicine.
[3] H. Balfour,et al. Multicenter collaborative trial of intravenous acyclovir for treatment of mucocutaneous herpes simplex virus infection in the immunocompromised host. , 1982, The American journal of medicine.
[4] J. Connor,et al. Pharmacokinetics of orally administered acyclovir in patients with herpes progenitalis. , 1982, The American journal of medicine.
[5] N. Flournoy,et al. Intravenous acyclovir to treat mucocutaneous herpes simplex virus infection after marrow transplantation: a double-blind trial. , 1982, Annals of internal medicine.
[6] O. Laskin,et al. ISOLATION AND CHARACTERISATION OF RESISTANT HERPES SIMPLEX VIRUS AFTER ACYCLOVIR THERAPY , 1982, The Lancet.
[7] C. Crumpacker,et al. Resistance to antiviral drugs of herpes simplex virus isolated from a patient treated with acyclovir. , 1982, The New England journal of medicine.
[8] J. Armstrong,et al. Herpes simplex infection in acute myelogenous leukemia and other hematologic malignancies: A prospective study , 1981, Cancer.
[9] O. Laskin,et al. Acyclovir prophylaxis of herpes-simplex-virus infections. , 1981, The New England journal of medicine.
[10] B. Bean,et al. ACYCLOVIR THERAPY FOR MUCOCUTANEOUS HERPES SIMPLEX INFECTIONS IN IMMUNOCOMPROMISED PATIENTS , 1981, The Lancet.
[11] N. Flournoy,et al. Infection with herpes simplex virus and cell-mediated immunity after marrow transplant. , 1980, The Journal of infectious diseases.
[12] P. Wiernik,et al. Potential of mezlocillin as empiric single-agent therapy in febrile granulocytopenic cancer patients , 1980, Antimicrobial Agents and Chemotherapy.
[13] P. de Miranda,et al. A sensitive radioimmunoassay for the antiviral agent BW248U [9-(2-hydroxyethoxymethyl)guanine]. , 1979, Analytical biochemistry.
[14] R. Whitley,et al. Identification of patients with increased risk of infection with herpes simplex virus after renal transplantation. , 1979, The Journal of infectious diseases.
[15] T. Merigan,et al. Cellular immunity and herpesvirus infections in cardiac-transplant patients. , 1977, The New England journal of medicine.
[16] N. Finter. Dye Uptake Methods for Assessing Viral Cytopathogenicity and their Application to Interferon Assays , 1969 .
[17] N. Mantel. Evaluation of survival data and two new rank order statistics arising in its consideration. , 1966, Cancer chemotherapy reports.
[18] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[19] David R. Cox,et al. Regression models and life tables (with discussion , 1972 .